Celebrex vs. Ketorolac
See how Celebrex and Ketorolac compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Celebrex is approved for long-term daily use in chronic arthritis conditions, while ketorolac is limited to 5 total days of use for acute pain.
Both drugs are NSAIDs with boxed warnings for cardiovascular and gastrointestinal risks, including bleeding and heart attack or stroke.
Ketorolac provides opioid-level relief for short-term severe pain, while Celebrex offers milder, ongoing relief for chronic conditions.
Celebrex vs. Ketorolac Drug Summary
Celebrex
Celebrex (celecoxib) is a COX-2 selective NSAID used to relieve pain and inflammation from osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and other conditions. It comes as an oral capsule taken once or twice daily, depending on the condition, and can be used long-term under a doctor's care.
Ketorolac
Ketorolac is a non-selective NSAID used for short-term treatment of moderately severe acute pain that would otherwise require opioid-level relief. It's available as an injection, oral tablet, nasal spray, or eye drop, but total use across all forms combined cannot exceed 5 days.
Celebrex vs. Ketorolac Side Effects
Celebrex
Ketorolac
Celebrex vs. Ketorolac Dosage
Celebrex
Ketorolac
| STAGE | DOSE | WHEN |
| Starting dose | 200 mg once daily | At the start |
| Maximum dose | 200 mg twice daily | Day 2 onward |
| Dose changes | 5 increases | Every day |
| STAGE | DOSE | WHEN |
| Starting dose | 30 mg IV/IM every 6 hrs | Days 1-5 |
| Maximum dose | 10 mg every 4-6 hrs PRN | Days 2-5 |
| Dose changes | 3 increases | Every day |
Celebrex
| STAGE | DOSE | WHEN |
| Starting dose | 200 mg once daily | At the start |
| Maximum dose | 200 mg twice daily | Day 2 onward |
| Dose changes | 5 increases | Every day |
Ketorolac
| STAGE | DOSE | WHEN |
| Starting dose | 30 mg IV/IM every 6 hrs | Days 1-5 |
| Maximum dose | 10 mg every 4-6 hrs PRN | Days 2-5 |
| Dose changes | 3 increases | Every day |
Celebrex vs. Ketorolac Indications
Celebrex
Celebrex is FDA-approved for several chronic and acute pain conditions, including osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. It's also approved for short-term acute pain, primary dysmenorrhea, and juvenile rheumatoid arthritis in children age 2 and older.
Osteoarthritis (OA)
Rheumatoid arthritis (RA)
Ankylosing spondylitis (AS)
Acute pain and primary dysmenorrhea
Juvenile rheumatoid arthritis (ages 2+)
Ketorolac
Ketorolac is FDA-approved only for short-term management of moderately severe acute pain that needs opioid-level relief, typically after surgery or injury. It is not approved for chronic pain, labor and delivery, or as a preventive pain medicine before major surgery.
Short-term (5 days or less) management of moderately severe acute pain
IV/IM injection for opioid-level analgesia in hospital or surgical settings
Oral tablets as continuation therapy after injectable dosing
Nasal spray (Sprix) for short-term acute pain
Ophthalmic solution for postoperative eye inflammation after cataract surgery
Celebrex vs. Ketorolac Pros and Cons
Celebrex
Celebrex's COX-2 selectivity gives it a somewhat lower risk of stomach ulcers than older NSAIDs, and it's approved for daily long-term use in chronic arthritis. Generic celecoxib is widely available, though it still carries the same class-wide cardiovascular and GI boxed warnings as other NSAIDs.
Pros
Approved for long-term daily use in chronic arthritis conditions
COX-2 selectivity may lower GI ulcer risk versus older NSAIDs
Oral-only dosing, no injections needed
Widely available as a low-cost generic (celecoxib)
Cons
Boxed warnings for heart attack, stroke, and GI bleeding risk
Not potent enough for severe, opioid-level acute pain
Contraindicated in patients with sulfonamide allergy
Requires periodic kidney and blood pressure monitoring with long-term use
Ketorolac
Ketorolac delivers strong, opioid-level pain relief without the sedation or dependence risks of opioids, making it useful for short-term severe pain after surgery or injury. Its power comes with tighter restrictions: a strict 5-day cap across all forms and several hard contraindications.
Pros
Delivers opioid-level pain relief without opioid sedation or dependence risk
Available as IV/IM injection for rapid onset in hospital settings
Nasal spray option allows needle-free dosing
Ophthalmic form treats post-cataract-surgery eye inflammation directly
Cons
Strict 5-day maximum use across all forms combined
Boxed warning against use before major surgery or during CABG
Not approved for pediatric use in injectable or oral forms
Contraindicated in labor, delivery, and breastfeeding
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.